Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Income from Continuing Operations (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Income from Continuing Operations data on record, last reported at 25533000.0 in Q4 2021.

  • For Q4 2021, Income from Continuing Operations fell 124.27% year-over-year to 25533000.0; the TTM value through Dec 2021 reached 75084000.0, up 8.5%, while the annual FY2025 figure was 321736000.0, 24.78% down from the prior year.
  • Income from Continuing Operations reached 25533000.0 in Q4 2021 per COGT's latest filing, down from 19704000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2301000.0 in Q4 2019 and bottomed at 57176000.0 in Q3 2020.
  • Average Income from Continuing Operations over 4 years is 13993875.0, with a median of 10950500.0 recorded in 2019.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 126.77% in 2019, then plummeted 594.78% in 2020.
  • A 4-year view of Income from Continuing Operations shows it stood at 8596000.0 in 2018, then surged by 126.77% to 2301000.0 in 2019, then tumbled by 594.78% to 11385000.0 in 2020, then crashed by 124.27% to 25533000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 25533000.0 in Q4 2021, 19704000.0 in Q3 2021, and 17172000.0 in Q2 2021.